Hiroaki Hara
Overview
Explore the profile of Hiroaki Hara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kikuchi H, Osawa T, Matsushita Y, Kojima T, Sazuka T, Hatakeyama S, et al.
Jpn J Clin Oncol
. 2025 Feb;
PMID: 39893579
Objective: To validate multiple prognostic models in metastatic renal cell carcinoma patients who received second-line axitinib following first-line nivolumab plus ipilimumab therapy. Methods: Five prognostic models (ACL, albumin, C-reactive protein,...
2.
Hara H, Takayanagi K, Shimizu T, Iwashita T, Ikari A, Maeshima A, et al.
Hypertens Res
. 2024 Dec;
48(3):1068-1079.
PMID: 39706885
Excessive fructose intake causes a variety of adverse conditions (e.g., obesity, hepatic steatosis, insulin resistance and uric acid overproduction). High fructose-induced hypertension is a particularly common and pathologically significant condition...
3.
Fujita K, Matsushita Y, Toyoda S, Kojima T, Yamashita S, Taniguchi H, et al.
World J Urol
. 2024 Sep;
42(1):536.
PMID: 39325218
Purpose: Metastatic non-clear cell renal cell carcinoma (nccRCC) is a heterogeneous disease with a poor prognosis and is treated with immunotherapy (IO)-based combinations according to the clear cell renal cell...
4.
Tomida R, Takahashi M, Matsushita Y, Kojima T, Yamana K, Kandori S, et al.
Clin Genitourin Cancer
. 2024 May;
22(3):102094.
PMID: 38714434
Background: To date, no studies have compared the treatment outcomes of second-line therapies in patients with metastatic clear cell renal cell carcinoma (ccRCC). This study retrospectively evaluated the efficacy of...
5.
Minami K, Osawa T, Kojima T, Hara T, Eto M, Takeuchi A, et al.
Urol Oncol
. 2023 Oct;
41(11):458.e9-458.e19.
PMID: 37798145
Objectives: Limited information is currently available on the efficacy and safety of axitinib for metastatic renal cell carcinoma (mRCC) patients with renal impairment. Therefore, the present study investigated the efficacy...
6.
Shimojima Y, Hirose Y, Nomura T, Takano K, Hara H, Bamba T, et al.
Oncol Lett
. 2023 Sep;
26(4):419.
PMID: 37674862
Metastatic choroidal carcinoma is rare and generally has a poor prognosis. The present case report describes a case of choroidal metastasis from distal cholangiocarcinoma, which was successfully managed using stereotactic...
7.
Hara H, Imamura T, Suzuki A, Ueno M, Minagawa T, Ogawa T, et al.
Low Urin Tract Symptoms
. 2022 Dec;
15(2):68-75.
PMID: 36543093
Objectives: Goto-Kakizaki (GK) rats with type 2 diabetes mellitus respond to low temperature (LT) environments with bladder overactivity, including increased voiding frequency and decreased voiding interval and micturition volume. We...
8.
Nagashima F, Miyazaki Y, Kanemaru E, Ezaka M, Hara H, Sugiura K, et al.
Redox Biol
. 2022 Dec;
59:102562.
PMID: 36470130
No abstract available.
9.
Murotani Y, Fujita H, Hara H, Harada H, Kataoka M, Okutani Y
Nagoya J Med Sci
. 2022 Apr;
84(1):185-199.
PMID: 35392010
Juvenile idiopathic arthritis (JIA) can lead to joint deformity and bone destruction, which can cause gait disturbances. To the best of our knowledge, there are no case reports with over...
10.
Ogawa T, Kanayama Y, Sasaki Y, Tokui K, Yasuda K, Hara H, et al.
ASAIO J
. 2021 Mar;
68(1):103-111.
PMID: 33741792
At most dialysis clinics in Japan, a central dialysis fluid delivery system (CDDS) is used primarily to provide consistent treatment to patients. We incorporated hot water disinfection to a CDDS...